Jorgensen Biotech Consulting ApS

CVR 42981761 · Private limited company (ApS) · Active · Medium risk

Jorgensen Biotech Consulting ApS is a Private limited company (ApS), founded on , based in Kongens Lyngby. The company is registered in the industry virksomhedsrådgivning og anden ledelsesrådgivning. Our model estimates a bankruptcy risk of 1.8% over the next 12 months, which is 1.3 times the average for Danish companies. 3 annual reports have been published. The latest annual report (30 Jun 2025) shows equity of DKK -134k and a net result of DKK -374k. CEO: Thomas Kjærsgaard Jørgensen.

Bankruptcy risk for Jorgensen Biotech Consulting ApS

1.8%
probability of bankruptcy within 12 months
Medium risk

1.3 × the average (1.41%) · higher risk than 81% of active Danish companies

Lowest riskHighest risk

Increases the risk

Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Equity ratio-50%–0% · bankruptcy rate 14.8%1.7×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×

Reduces the risk

Gross profit growth10%–30% · bankruptcy rate 4.5%0.51×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×
Qualification / emphasis of matterNo · bankruptcy rate 7.1%0.80×
Missed filing deadlines0 · bankruptcy rate 7.1%0.81×
CEO's other companies1 · bankruptcy rate 7.3%0.83×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
42981761
Status
Active
Company type
Private limited company (ApS)
Founded
(4 years)
Address
Dronningens Vænge 11, st. tv
2800 Kongens Lyngby
Municipality
Lyngby-Taarbæk
Industry
Virksomhedsrådgivning og anden ledelsesrådgivning (702000)
Bankruptcies in the industry: Virksomhedsrådgivning og anden rådgivning om driftsledelse
Share capital
DKK 40k
Auditor
BDO Statsautoriseret Revisionspartnerselskab
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 3
Missing annual reportNo
Negative equityYes
Equity ratio-14.5%
Current ratio87%
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 2.7mDKK 2.4m
Net profitDKK -374kDKK 247k
EquityDKK -134kDKK 361k
Total assetsDKK 927kDKK 1.3m
CashDKK 390k–
Short-term debtDKK 1.1m–
Tax owedDKK 70k–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · BDO Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jul 2024 – 30 Jun 2025121
1 Jul 2023 – 30 Jun 202485
10 Jan 2022 – 30 Jun 2023105

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOThomas Kjærsgaard JørgensenCurrent
Owner (100%)JoBiCo Holding ApSCurrent
FounderJoBiCo Holding ApSCurrent

The CEOs' other companies

Thomas Kjærsgaard Jørgensen – 1 other companies

Address history (1 moves)

Dronningens Vænge 11, st. tv, 2800 Kongens Lyngby
Ermelundsvej 90A, 1. tv, 2820 Gentofte

Other companies at the same address

Similar companies in Lyngby-Taarbæk

Questions and answers about Jorgensen Biotech Consulting ApS

Has Jorgensen Biotech Consulting ApS gone bankrupt?

No, Jorgensen Biotech Consulting ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Jorgensen Biotech Consulting ApS?

Our model estimates a bankruptcy risk of 1.8% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.

Who is the CEO of Jorgensen Biotech Consulting ApS?

Thomas Kjærsgaard Jørgensen is the CEO of Jorgensen Biotech Consulting ApS.

Who is the auditor of Jorgensen Biotech Consulting ApS?

Jorgensen Biotech Consulting ApS most recently used BDO Statsautoriseret Revisionspartnerselskab.

When was Jorgensen Biotech Consulting ApS founded?

Jorgensen Biotech Consulting ApS was founded on 10 January 2022.

What is the equity of Jorgensen Biotech Consulting ApS?

Equity was DKK -134k according to the annual report for the period ending 30 June 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.